JFS Wealth Advisors’s St Jude Medical STJ Stock Holding History

JFS Wealth Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,751	Closed	-$221K	–	478
2017 Q1	$221K	Hold	2,751	–	–	0.06%	117
2016 Q4	$221K	Hold	2,751	–	–	0.06%	117
2016 Q3	$219K	Hold	2,751	–	–	0.06%	122
2016 Q2	$215K	Sell	2,751 -28	-1%	-$2K	0.06%	148
2016 Q1	$153K	Buy	2,779 +28	+1%	+$1.53K	0.05%	151
2015 Q4	$170K	Sell	2,751 -317	-10%	-$20K	0.05%	148
2015 Q3	$194K	Hold	3,068	–	–	0.09%	104
2015 Q2	$224K	Sell	3,068 -15	-0.5%	-$1.08K	0.12%	83
2015 Q1	$202K	Sell	3,083 -12	-0.4%	-$798	0.09%	89
2014 Q4	$201K	Buy	3,095 +27	+0.9%	+$1.74K	0.03%	87
2014 Q3	$184K	Sell	3,068 -13	-0.4%	-$849	0.03%	84
2014 Q2	$213K	Hold	3,081	–	–	0.04%	83
2014 Q1	$201K	Buy	+3,081	New	+$201K	0.11%	109
2013 Q3	–	Sell	-6,703	Closed	-$306K	–	132
2013 Q2	$306K	Buy	+6,703	New	+$290K	0.15%	89

Other funds holding STJ

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

JFS Wealth Advisors's STJ Position: Q2 2017 in Review

JFS Wealth Advisors sold out of St Jude Medical (STJ) in Q2 2017, closing a stake of 2,751 shares — an estimated $221K sold.

JFS Wealth Advisors first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $306K in Q2 2013. 1 fund tracked by Wall St. Rank holds STJ as of Q2 2017.

JFS Wealth Advisors reported no remaining St Jude Medical position as of Q2 2017 after selling out during the quarter.
JFS Wealth Advisors sold 2,751 St Jude Medical shares in Q2 2017, an estimated $221K.
JFS Wealth Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
JFS Wealth Advisors's St Jude Medical position peaked at $306K in Q2 2013.
1 fund tracked by Wall St. Rank held St Jude Medical as of Q2 2017.

Based on JFS Wealth Advisors's 13F filing for Q2 2017, filed 28 Jul 2017.